Aprea Therapeutics
APRE
APRE
64 hedge funds and large institutions have $404M invested in Aprea Therapeutics in 2020 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 23 increasing their positions, 16 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 8
37% less capital invested
Capital invested by funds: $639M → $404M (-$234M)
Holders
64
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$4.99M | |
| 2 | +$3.06M | |
| 3 | +$2.48M | |
| 4 |
PAI
Palo Alto Investors
Palo Alto,
California
|
+$1.75M |
| 5 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$1.41M |
Top Sellers
| 1 | -$6.14M | |
| 2 | -$5.65M | |
| 3 | -$2.25M | |
| 4 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
-$481K |
| 5 |
SAMH
Shanda Asset Management Holdings
Tortola,,
British Virgin Islands
|
-$460K |